Winton Group LTD Lantheus Holdings, Inc. Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 30, 2020	SELL	$11.98 - $16.34 $1.38 Million - $1.88 Million	-115,151 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$10.34 - $15.51 $1.3 Million - $1.95 Million	-125,521 Reduced 52.15%	115,151 $1.65 Million
Q1 2020 May 11, 2020	SELL	$9.11 - $20.05 $668,801 - $1.47 Million	-73,414 Reduced 23.37%	240,672 $3.07 Million
Q4 2019 Feb 13, 2020	BUY	$18.47 - $24.03 $5.8 Million - $7.55 Million	314,086 New	314,086 $6.44 Million
Q3 2019 Nov 08, 2019	SELL	$21.01 - $28.94 $441,041 - $607,508	-20,992 Closed	0 $0
Q2 2019 Jul 08, 2019	BUY	$23.33 - $28.3 $489,743 - $594,073	20,992 New	20,992 $594,000
Q3 2018 Nov 02, 2018	SELL	$13.1 - $16.35 $274,995 - $343,219	-20,992 Closed	0 $0
Q2 2018 Aug 20, 2018	SELL	$13.65 - $18.7 $228,064 - $312,439	-16,708 Reduced 44.32%	20,992 $0
Q1 2018 May 21, 2018	BUY	$14.85 - $24.3 $559,845 - $916,110	37,700 New	37,700 $0

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.25B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.